The effects of dopaminergic D2 stimulation and blockade on smoking behavior
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dopamine antagonists such as antipsychotics decrease pleasure, reinforcement and reward of tobacco smoking, which might result in heavier smoking.
“Treatment might be complicated by the fact that dopamine antagonists such as antipsychotics decrease pleasure, reinforcement and reward of tobacco smoking, which, in turn, might result in heavier smoking (66).”
From The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review (2023) · cites this paper as [66]
Cited by
Sorted by citations
Genetics of dopamine receptors and drug addiction: a comprehensive review
Foll, B. L., Gallo, A., Strat, Y. L., Lü, L., & Gorwood, P. A. P. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 387 · see citing works
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & de Wit, H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240 · see citing works
Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents
Newman, A. H., Grundt, P., & Nader, M. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040190e · Cited by 191 · see citing works
DiFranza, J. R., & Wellman, R. J. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200412331328538 · Cited by 190 · see citing works
Laviolette, S. R., & van der Kooy, D. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001197 · Cited by 180 · see citing works
Translational research in medication development for nicotine dependence
Lerman, C. E., LeSage, M. G., Perkins, K. A., O’Malley, S. S., Siegel, S. J., Benowitz, N. L., & Corrigall, W. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2361 · Cited by 149 · see citing works
Andreoli, M., Tessari, M., Pilla, M. A., Valerio, E., Hagan, J. J., & Heidbreder, C. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300183 · Cited by 138 · see citing works
The role of dopamine in human addiction: From reward to motivated attention
Franken, I. H. A., Booij, J., & van den Brink, W. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.025 · Cited by 122 · see citing works
Secondhand Smoke Exposure and Depressive Symptoms
Bandiera, F. C., Arheart, K. L., Caban-Martinez, A. J., Fleming, L. E., McCollister, K. E., Dietz, N. A., LeBlanc, W. G., Davila, E. P., Lewis, J. E., Serdar, B., et al. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181c6c8b5 · Cited by 110 · see citing works
Pak, A. C., Ashby, C. R., Heidbreder, C. A., Pilla, M. A., Gilbert, J. G., Xi, Z., & Gardner, E. L. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006560 · Cited by 88 · see citing works
Papke, R. L., Dwoskin, L. P., & Crooks, P. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04355.x · Cited by 83 · see citing works
Erblich, J., Lerman, C. E., Self, D. W., Díaz, G. A., & Bovbjerg, D. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001588 · Cited by 76 · see citing works
Sorge, R. E., & Clarke, P. B. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154641 · Cited by 71 · see citing works
Venugopalan, V. V., Casey, K. F., O'Hara, C., O'Loughlin, J., Benkelfat, C., Fellows, L. K., & Leyton, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.135 · Cited by 70 · see citing works
Tobacco use in bipolar disorder
Thomson, D., Berk, M., Dodd, S., Rapado-Castro, M., Quirk, S. E., Ellegaard, P. K., Berk, L., & Dean, O. M. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.1 · Cited by 63 · see citing works
Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms
Erblich, J., Lerman, C. E., Self, D. W., Díaz, G. A., & Bovbjerg, D. H. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500227 · Cited by 63 · see citing works
Hitsman, B. L., MacKillop, J. M., Lingford-Hughes, A. R., Williams, T. A., Ahmad, F., Adams, S. H., Nutt, D., & Munafo, M. R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0995-5 · Cited by 61 · see citing works
Laviolette, S. R., Lauzon, N. M., Bishop, S. F., Sun, N., & Tan, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1371-08.2008 · Cited by 58 · see citing works
Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers
Casey, K. F., Benkelfat, C., Young, S. N., & Leyton, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.002 · Cited by 54 · see citing works
Pharmacogenetics of Nicotine and Associated Smoking Behaviors
Tanner, J., Chenoweth, M. J., & Tyndale, R. F. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_3 · Cited by 55 · see citing works
Bahk, J. Y., Li, S., Park, M. S., & Kim, M. O. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00243-9 · Cited by 46 · see citing works
Dutra, S. J., Stoeckel, L. E., Carlini, S. V., Pizzagalli, D. A., & Evins, A. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2373-6 · Cited by 40 · see citing works
The Role of Antipsychotics in Smoking and Smoking Cessation
Matthews, A. M., Wilson, V. B., & Mitchell, S. H. (2011) · CNS Drugs · doi:10.2165/11588170-000000000-00000 · Cited by 38 · see citing works
Resting-state EEG, impulsiveness, and personality in daily and nondaily smokers
Rass, O., Ahn, W., & O’Donnell, B. F. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.05.007 · Cited by 34 · see citing works
Effect of Nonnicotine Pharmacotherapy on Smoking Behavior
Kotlyar, M., Golding, M., Hatsukami, D. K., & Jamerson, B. D. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.20.1530.34477 · Cited by 32 · see citing works
Effects of haloperidol on reactions to smoking cues in humans
Mahler, S. V., & de Wit, H. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00008 · Cited by 27 · see citing works
O’Dell, L. E., & Nazarian, A. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.005 · Cited by 27 · see citing works
Reuter, M., Netter, P., Toll, C., & Hennig, J. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00329-3 · Cited by 27 · see citing works
Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory
Bisaga, A. M., Padilla, M., Garawi, F., Sullivan, M. A., & Haney, M. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.816 · Cited by 25 · see citing works
Bromocriptine use is associated with decreased smoking rates
Murphy, M. F., Hey, K., Johnstone, E. C., Munafo, M. R., Walton, R. J., WILLIS, B., & Harrison, P. J. (2002) · Addiction Biology · doi:10.1080/13556210220139550 · Cited by 20 · see citing works
Chausmer, A. L., Smith, B. J., Kelly, R. Y., & Griffiths, R. R. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200303000-00002 · Cited by 15 · see citing works
Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward
Freeman, T. P., Das, R., Kamboj, S. K., & Curran, H. V. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsu026 · Cited by 14 · see citing works
Neurobiologic Basis of Nicotine Addiction and Psychostimulant Abuse: a Role for Neurotensin?
Fredrickson, P. A., Boules, M., Lin, S.-C., & Richelson, E. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.05.001 · Cited by 10 · see citing works
Grunze, A., Mosolov, S., Grunze, H., & Born, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1114432 · Cited by 11 · see citing works
Richardson, M., Powell, J. H., & Curran, H. V. (2003) · Neuropsychological Rehabilitation · doi:10.1080/09602010343000011 · Cited by 8 · see citing works
Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia
Wehring, H. J., Heishman, S. J., McMahon, R. P., Liu, F., Feldman, S. M., Raley, H., Weiner, E., & Kelly, D. L. (2017) · Journal of Dual Diagnosis · doi:10.1080/15504263.2017.1288946 · Cited by 8 · see citing works
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia
Montoya, I. D., & Vocci, F. J. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_09 · Cited by 7 · see citing works
Aripiprazole Therapy for Nicotine Dependence
Ramaswamy, S. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0109b · Cited by 5 · see citing works
Dargaud, Y. G., Pariset, C., Pinède, L., et al. (2004) · Lupus · doi:10.1191/0961203304lu2016cr · Cited by 5 · see citing works
Methylphenidate-Induced Neuroleptic Malignant Syndrome
Basil, B., Mathews, M., & Budur, K. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0109a · Cited by 5 · see citing works
Acute Effects of Nicotine on Risky Choice among Non-Smokers
Pilarski, C. R., Skeel, R. L., & Reilly, M. P. (2014) · The Psychological Record · doi:10.1007/s40732-014-0057-4 · Cited by 4 · see citing works
Childhood Depression As Emerging Public Health Problem: A Systematic Review
Pimentel, J. V. C., Júnior, C. R. P. G., Júnior, A. G. T., Santos, M. F. A., Meireles, C. B., Maia, L. C., Miná, V. A. L., Pinheiro, P. P., Pereira, M. A. M., Sampaio, A. R. R., et al. (2015) · International Archives of Medicine · doi:10.3823/1830 · Cited by 1 · see citing works
Treatment of Nicotine Dependence
Foll, B. L. (2006) · CRC Press eBooks · doi:10.1201/9781420005431.ch21
- Authors
- Caskey, N. H., Jarvik, M. E., & Wirshing, W. C.
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 1999-02
- Volume
- 7
- Issue
- 1
- Pages
- 72-78
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- OpenAlex
- W4234638016
- Cited by
- 43
- References
- 0
- Citations by year
- 2023: 1 · 2017: 1 · 2015: 5 · 2014: 2
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Psychopharmacology (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- dopamine D2 receptor, dopaminergic stimulation, dopaminergic blockade, smoking behavior, nicotine, tobacco use
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review